• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ERBB1和ERBB2阳性的甲状腺髓样癌:病例报告

ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report.

作者信息

Minuto Michele, Varaldo Emanuela, Marcocci Gianluca, de Santanna Amleto, Ciccone Ermanno, Cortese Katia

机构信息

DISC, Department of Surgical Sciences, University of Genoa, Largo R. Benzi, 8, 16132 Genoa, Italy.

DIMES, Department of Experimental Medicine, University of Genoa, Via Antonio de Toni 14, 16132 Genoa, Italy.

出版信息

Diseases. 2018 Apr 10;6(2):25. doi: 10.3390/diseases6020025.

DOI:10.3390/diseases6020025
PMID:29642647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6023302/
Abstract

Medullary thyroid carcinomas (MTCs) are rare thyroid tumors occurring in both sporadic and hereditary forms, whose pathogenesis is related to RET proto-oncogene alterations. MTCs originate from parafollicular cells, which produce calcitonin that represents the biochemical activity of MTC. Total thyroidectomy is the main treatment for MTC and often cures patients with confined diseases. In the presence of metastasis, the therapeutic approach depends on the rate of disease progression. We report a case of a 54-year-old female with a single, incidentally discovered, thyroid nodule of 1 cm, classified as suspicious MTC after a stimulation test with intravenous (iv) calcium. After surgery, we examined the nodule using immunohistochemistry, immunofluorescence, and electron microscopy. In addition to calcitonin, we found that it expressed intracellular positivity for the tyrosine kinase RTK receptors ERBB1 and ERBB2. Consistently with MTC features, the ultrastructural examination of the tumor displayed heterogeneous spindle-shaped cells containing two groups of secretory granules. Because of the significant correlation found between high ERBB1/ERBB2 levels in MTCs and extrathyroidal growth, the detection of ERBB1 and ERBB2 expression suggests that the two oncoproteins may be involved in the tumor proliferative responses and/or in the differentiation of parafollicular C-cells. The biological, prognostic, and therapeutic significance of these patterns would merit further investigations.

摘要

甲状腺髓样癌(MTC)是一种罕见的甲状腺肿瘤,有散发性和遗传性两种形式,其发病机制与RET原癌基因改变有关。MTC起源于滤泡旁细胞,这些细胞产生降钙素,而降钙素代表了MTC的生化活性。甲状腺全切术是MTC的主要治疗方法,通常能治愈局限性疾病的患者。出现转移时,治疗方法取决于疾病进展速度。我们报告一例54岁女性病例,其偶然发现一个1厘米的甲状腺结节,经静脉注射钙剂刺激试验后分类为可疑MTC。手术后,我们通过免疫组织化学、免疫荧光和电子显微镜检查该结节。除降钙素外,我们发现它对酪氨酸激酶RTK受体ERBB1和ERBB2呈细胞内阳性表达。与MTC特征一致,肿瘤的超微结构检查显示有含两组分泌颗粒的异质性梭形细胞。由于在MTC中发现ERBB1/ERBB2高表达水平与甲状腺外生长之间存在显著相关性,ERBB1和ERBB2表达的检测表明这两种癌蛋白可能参与肿瘤增殖反应和/或滤泡旁C细胞的分化。这些模式的生物学、预后和治疗意义值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/766803e5d69b/diseases-06-00025-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/1968af9eeb6b/diseases-06-00025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/6311bccbf51e/diseases-06-00025-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/39f560b66eab/diseases-06-00025-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/766803e5d69b/diseases-06-00025-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/1968af9eeb6b/diseases-06-00025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/6311bccbf51e/diseases-06-00025-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/39f560b66eab/diseases-06-00025-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b09f/6023302/766803e5d69b/diseases-06-00025-g004.jpg

相似文献

1
ERBB1- and ERBB2-Positive Medullary Thyroid Carcinoma: A Case Report.ERBB1和ERBB2阳性的甲状腺髓样癌:病例报告
Diseases. 2018 Apr 10;6(2):25. doi: 10.3390/diseases6020025.
2
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
3
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.散发性甲状腺髓样癌中RET原癌基因的体细胞突变。
Clin Endocrinol (Oxf). 1996 Mar;44(3):249-57. doi: 10.1046/j.1365-2265.1996.681503.x.
4
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.遗传性和散发性甲状腺髓样癌的基因诊断的临床实用性。
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.
5
[Total thyroidectomy in C-cell hyperplasia of the thyroid gland].[甲状腺C细胞增生的甲状腺全切除术]
Med Pregl. 2003 Sep-Oct;56(9-10):481-4. doi: 10.2298/mpns0310481s.
6
Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.RET 原癌基因突变的多样性及其在甲状腺髓样癌中的致癌机制。
Crit Rev Clin Lab Sci. 2016 Aug;53(4):217-27. doi: 10.3109/10408363.2015.1129529. Epub 2016 Jan 27.
7
Serum calcitonin negative medullary thyroid carcinoma.血清降钙素阴性的甲状腺髓样癌
World J Surg Oncol. 2006 Dec 21;4:97. doi: 10.1186/1477-7819-4-97.
8
Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.散发性甲状腺髓样癌的手术治疗策略:我们的经验
G Chir. 2012 Nov-Dec;33(11-12):395-9.
9
New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.RET原癌基因中的新突变——L881V,与甲状腺髓样癌相关;以及——R770Q,在一名患有混合性髓样/滤泡性甲状腺肿瘤的患者中发现。
Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):550-3. doi: 10.1055/s-0029-1241851. Epub 2009 Dec 11.
10
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.2型多发性内分泌腺瘤病和甲状腺髓样癌中的RET原癌基因突变
Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461.

引用本文的文献

1
The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2 breast cancer cells.染色质结构域解旋酶CHD4调节ERBB2乳腺癌细胞中的ERBB2信号通路和自噬。
Biol Open. 2019 Apr 18;8(4):bio038323. doi: 10.1242/bio.038323.

本文引用的文献

1
Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.髓样甲状腺癌:散发性疾病检测中生存分析及突变特异性免疫组化评估
World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8.
2
Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs.卡博替尼和凡德他尼治疗甲状腺髓样癌:线粒体功能及其作为设计抗癌症干细胞药物新策略的治疗靶点的潜力
Cancer Biol Ther. 2018;19(10):847-849. doi: 10.1080/15384047.2018.1433495. Epub 2018 Aug 17.
3
Recent advances in the biology and therapy of medullary thyroid carcinoma.
甲状腺髓样癌生物学与治疗的最新进展
F1000Res. 2017 Dec 28;6:2184. doi: 10.12688/f1000research.12645.1. eCollection 2017.
4
Targeted Therapy for Medullary Thyroid Cancer: A Review.甲状腺髓样癌的靶向治疗:综述
Front Oncol. 2017 Oct 6;7:238. doi: 10.3389/fonc.2017.00238. eCollection 2017.
5
Medullary Thyroid Carcinoma-We Should Do Better.甲状腺髓样癌——我们应做得更好。
JAMA Surg. 2018 Jan 1;153(1):59. doi: 10.1001/jamasurg.2017.3894.
6
Revising the embryonic origin of thyroid C cells in mice and humans.修正小鼠和人类甲状腺C细胞的胚胎起源。
Development. 2015 Oct 15;142(20):3519-28. doi: 10.1242/dev.126581. Epub 2015 Sep 22.
7
Progress in adjuvant chemotherapy for breast cancer: an overview.乳腺癌辅助化疗的进展:综述
BMC Med. 2015 Aug 17;13:195. doi: 10.1186/s12916-015-0439-8.
8
Endosomal signaling and oncogenesis.内体信号传导与肿瘤发生。
Methods Enzymol. 2014;535:179-200. doi: 10.1016/B978-0-12-397925-4.00012-2.
9
Expression and Localization of Neuregulin-1 (Nrg1) and ErbB2/ErbB4 Receptors in Main Endocrine Organs of the Rhesus Monkey.神经调节蛋白-1(Nrg1)和ErbB2/ErbB4受体在恒河猴主要内分泌器官中的表达与定位
Int J Endocrinol Metab. 2013 Summer;11(3):162-6. doi: 10.5812/ijem.9871. Epub 2013 Jul 1.
10
New targeted therapies for thyroid cancer.甲状腺癌的新型靶向治疗方法。
Curr Genomics. 2011 Dec;12(8):626-31. doi: 10.2174/138920211798120808.